Second Mysterious Drug-Price Rule Surfaces Thursday

October 18, 2018
The White House’s budget office on Thursday (Oct. 18) began reviewing yet another Medicare regulation related to drug prices, and as with other regulations, no one is sure what it entails or how it fits into the administration’s overall effort to curb drug prices. Most observers of the rules agree that the wave of regulations is likely due to the president pressuring HHS to act on drug prices before the elections, and although rumors on which rules will likely be...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.